Covered recipient · General Payments record
REYNARIA N PITTS
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$13,571.23
- Reported across 323 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,090.00 | 4 |
| Food and Beverage | $1,540.31 | 51 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $1,210.00 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $973.88 | 5 |
| ATRICURE, INC. | $210.70 | 1 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $162.72 | 3 |
| Abbott Laboratories | $159.43 | 2 |
| Merck Sharp & Dohme Corporation | $116.74 | 5 |
| BOSTON SCIENTIFIC CORPORATION | $110.80 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $88.01 | 4 |
| PFIZER INC. | $61.22 | 3 |
| HEARTFLOW, INC. | $58.73 | 3 |
| Janssen Pharmaceuticals, Inc | $51.52 | 3 |
| SCPHARMACEUTICALS INC. | $50.51 | 2 |
| Kiniksa Pharmaceuticals International, plc | $50.09 | 2 |
| E.R. Squibb & Sons, L.L.C. | $49.38 | 2 |
| Philips Electronics North America Corporation | $48.30 | 2 |
| Novo Nordisk AS | $40.32 | 2 |
| Lexicon Pharmaceuticals, Inc. | $37.82 | 2 |
| ABIOMED | $31.73 | 1 |
| Edwards Lifesciences Corporation | $26.30 | 1 |
| Kestra Medical Technology Services, Inc. | $21.39 | 1 |
| Acerta Pharma LLC | $20.02 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.35 | 1 |
| AngioDynamics, Inc. | $16.77 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $16.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.